Register

Login

Vet Times logo
+
  • View all news
  • Vets news
  • Vet Nursing news
  • Business news
  • + More
    • Videos
    • Podcasts
    • Crossword
  • View all clinical
  • Small animal
  • Livestock
  • Equine
  • Exotics
  • All Jobs
  • Your ideal job
  • Post a job
  • Career Advice
  • Students
About
Contact Us
For Advertisers
NewsClinicalJobs
Vet Times logo

Vets

All Vets newsSmall animalLivestockEquineExoticWork and well-beingOpinion

Vet Nursing

All Vet Nursing newsSmall animalLivestockEquineExoticWork and well-beingOpinion

Business

All Business newsHuman resourcesBig 6SustainabilityFinanceDigitalPractice profilesPractice developments

+ More

VideosPodcastsDigital EditionCrossword

The latest veterinary news, delivered straight to your inbox.

Choose which topics you want to hear about and how often.

Vet Times logo 2

About

The team

Advertise with us

Recruitment

Contact us

Vet Times logo 2

Vets

All Vets news

Small animal

Livestock

Equine

Exotic

Work and well-being

Opinion

Vet Nursing

All Vet Nursing news

Small animal

Livestock

Equine

Exotic

Work and well-being

Opinion

Business

All Business news

Human resources

Big 6

Sustainability

Finance

Digital

Practice profiles

Practice developments

Clinical

All Clinical content

Small animal

Livestock

Equine

Exotics

Jobs

All Jobs content

All Jobs

Your ideal job

Post a job

Career Advice

Students

More

All More content

Videos

Podcasts

Digital Edition

Crossword


Terms and conditions

Complaints policy

Cookie policy

Privacy policy

fb-iconinsta-iconlinkedin-icontwitter-iconyoutube-icon

© Veterinary Business Development Ltd 2025

IPSO_regulated

10 Feb 2022

Vet Times Extra: Alison Lambert on communication in the cardio consult – owner insights

Onswitch founder Alison Lambert discusses how COVID-19 has highlighted the critical importance of how we communicate with clients and how owners hear messages about the pets they live with.

Alison Lambert, Paul Imrie

Job Title



Vet Times Extra: Alison Lambert on communication in the cardio consult – owner insights

Alison will be speaking to delegates about practices creating a “unique and engaging” customer experience.

Ceva Animal Health is passionate about supporting the pet and their owner through diagnosis and management of congestive heart failure, which is why it is supporting this podcast.

Alison Lambert (founder of Onswitch) will share the results from Ceva’s novel pet owner research that helps you understand what matters to owners when their pet is diagnosed with this common condition.

Based on the research insights discussed, Ceva has developed an owner roadmap leaflet describing all the stages of mitral valve disease – download the mitral valve disease owner roadmap here.

To download the sleeping respiratory rate app visit the App or Google Play store and search for “Cardalis”. Finally to complete the Managing Mitral Valve Disease CPD miniseries with Alison Lambert and Mike Martin, visit veterinarywebinars.com/community/ceva/

Alison Lambert BVSc CMRS MRCVS

Alison is a Yorkshire farmer’s daughter, who qualified as a vet from the University of Liverpool in 1989. She worked in practice for several years before pursuing a career with Hill’s Pet Nutrition and Mars, discovering the customer experience passion that led her to establish Onswitch in 2001.

Alison is honorary associate professor at the University of Nottingham’s School of Veterinary Medicine and Science. She is published widely, regularly speaks at key international veterinary congresses and events, and was given the Australian Veterinary Assocation’s Veterinary Business Thought Leader award in 2019.

 

SPONSORED

This podcast is brought to you by Ceva Animal Health, experts in veterinary cardiology and manufacturers of Cardalis, Isemid, Libeo and now Zelys.

160,000 users is combined download data for the Cardalis App as of 9 February 2022.

CARDALIS® 2.5 mg/20 mg chewable tablets for dogs. ACTIVE SUBSTANCE: Benazepril hydrochloride (HCl) 2.5 mg – Spironolactone 20 mg. CARDALIS® 5 mg/40 mg chewable tablets for dogs. ACTIVE SUBSTANCE: Benazepril hydrochloride (HCl) 5 mg – Spironolactone 40 mg. CARDALIS® 10 mg/80 mg chewable tablets for dogs. ACTIVE SUBSTANCE: Benazepril hydrochloride (HCl) 10 mg – Spironolactone 80 mg.
Further information on contraindications, warnings and side eff ects, can be found in the SPC data sheet or pack leaflet before use. Legal Category:   POM-V   UK   POM   IE
Use medicines responsibly (www.noah.co.uk/responsible)